Abacus Health Products, Inc. (CSE: ABCS) will release its 2019 first quarter financial results on Thursday, May 30, 2019, after market close. Management will host a conference call the following day, Friday, May 31, 2019, at 10:00 AM Eastern Time to review the financial results.
Abacus Health Products, Inc. (CSE: ABCS) announced the closing of its bought deal offering of 2,464,450 units including the exercise, in full, of the Underwriters’ over-allotment option for gross proceeds of $34,502,300.
Abacus Health Products, Inc. (CSE: ABCS) released the financial results of its operating subsidiary, Abacus Health Products, Inc., a Delaware corporation, for the 12-month period ending December 31, 2018, being a period completed prior to the closing of the Company’s reverse takeover transaction with Abacus U.S. completed on January 29, 2019 .
James Barkat has been named Vice President of Marketing for Abacus. Prior to joining the Company, Mr. Barkat spent over ten years at Sanofi Consumer Health, where he most recently served as U.S.
These new orders from five U.S. retail chains, including CVS Pharmacy, Weis Markets, and Pharmacare
Inc, bring CBDMEDIC products to over 1100 pharmacy and supermarket retail locations throughout the